Indian Child Growth Reference Initiative Dr Pratibha D Dr Santu Ghosh Dr Tinku Dr Deepthi N Shanbhag Dr Suman Rao
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - Ongoing
Project Lead
Authors
Dr Pratibha D Dr Santu Ghosh Dr Tinku Dr Deepthi N Shanbhag Dr Suman Rao
Project Status
ongoing